Akerna Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)

6 Months Ended

Jun. 30, 2023

Schedule of share based compensation stock warrant activity

	Exercise Price		Expiration Date	Balance as of December 31, 2022		Issued		Exercised		Expired		Balance as of June 30, 2023
2019 Public Warrants (1)	$	230.00	6/19/2024		5,813,804		—		—		—		5,813,804
2022 Unit Offering
Common Warrants (2)	$	0.37	6/29/2027		43,478,261		—		—		—		43,478,261
Underwriter Warrants (2)	$	0.37	6/29/2027		2,173,913		—		—		—		2,173,913
					51,465,978		—		—		—		51,465,978

(1) The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.

(2) In connection with the PIPE Investment, the exercise price of the Common Warrants and Underwriter Warrants was reduced from $0.88 per shares to $0.37 per share and are exercisable for a combined amount of 2,282,609 shares of Common Stock at $0.37 per share or a ratio of 20 warrants for one share of Common Stock.